Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed, and several help/navigation items were added while two formatting/version notes were removed or updated.
    Difference
    0.4%
    Check dated 2026-06-13T01:32:58.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    New site revision displayed as Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a platform update rather than changes to the study details or study content.
    Difference
    0.1%
    Check dated 2026-06-05T21:55:20.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page's revision tag was updated from Revision: v3.5.3 to Revision: v3.5.4. This reflects a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-05-15T14:24:04.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows an updated ClinicalTrials.gov site revision label (from v3.5.2 to v3.5.3), reflecting a version change for the website interface rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:38.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:41.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed. This appears to be a site version update with no impact on the study details or data.
    Difference
    0.1%
    Check dated 2026-03-19T06:10:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.